Healthify is banking on the rise of GLP-1 weight-loss drugs in India, integrating them with lifestyle coaching. The firm ...

There are currently no drugs approved in the European Union to treat the liver condition known as MASH, but a new trial of ...

There are several decision tools to help doctors and patients evaluate the potential benefits of cholesterol medication, and ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic dysfunction-associated steatohepatitis (MASH) ...

Sodium-glucose cotransporter-2 inhibitors (SGLT2i), or gliflozins, are medications used in the treatment of type 2 diabetes ...

Diabetes insipidus affects the kidneys but does not concern blood sugar control like diabetes mellitus. Learn about the ...

As broader approval for GLP-1 weight loss drugs spurs higher demand, it’s also causing employer drug spending to spike.

This inexpensive generic significantly reduced knee pain in a small trial of people who are overweight or have obesity.

The U.S. Diabetes Prevention Program, or DPP, reported on April 28 the 21-year follow-up of a randomized clinical trial, ...

Opioids, antidepressants, and some NSAIDs increase the risk of constipation. Find out which ones do and what helps bowel ...

Advancing diabetes therapy requires an integrative approach that uses emerging technologies. This research topic focuses on the synergy between ...

A judge denied compounders' request to keep making off-brand Wegovy and Ozempic after the FDA removed semaglutide from its shortage list.